UnitedHealthcare Awards $11M in Grants to Address Social Determinants of Health
What You Should Know: – Health insurer UnitedHealthcare has donated $11M in grants to nonprofit organizations across 11 states. – These grants are part of […]
What You Should Know: – Health insurer UnitedHealthcare has donated $11M in grants to nonprofit organizations across 11 states. – These grants are part of […]
Mark Doyle, co-founder of The Method and creator of the A Life in a Day programme, tells us about the immersive experience he and his […]
What You Should Know: – One Drop, a leader in precision health solutions for people living with diabetes and other chronic conditions, announced outcomes from […]
It is time to shift the conversation, incentives, and policy solutions to help people improve their health and get off of medications—not just make them […]
Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to help keep their glucose levels in check. […]
The company has $20 million in funding, including $16 million from a Series A funding round announced Wednesday, and backing from the veteran health executive […]
Mark Clements, MD, PhD, CPI, FAAP, Chief Medical Officer, Glooko, Inc. If you’re looking for a silver lining in the COVID-19 dark cloud still enshrouding […]
What You Should Know: – Hitachi, U of U Health, and Regenstrief researchers partnered to develop and test a new AI method to improve personalized […]
BioCoach will use its $4 million seed funding from SecretLab LLC founder Jason Bright to scale its platform that tackles prediabetes by offering customized diet […]
What You Should Know: – VillageMD announced it has acquired Healthy Interactions, which helps patients manage chronic conditions through interactive educational programming as part of […]
By enhancing traditional in-person care with on-demand digital solutions, we can create a powerful new care model that maximizes clinical resources while meeting patients whenever […]
What You Should Know: – DreaMed Diabetes AI, developer of the AI-powered Advisor Pro Clinical Decision Support System and expert-care platform for diabetes, announced today […]
Shots: Glenmark has launched Remogliflozin (SGLT2 inhibitors, 100mg, ) + Vildagliptin (DPP4 inhibitors, 50mg,) + Metformin (500/1000mg) as FDC for the management of T2D in […]
Shots: The SURPASS-4 study evaluates the efficacy & safety of tirzepatide (5/10/15mg) vs insulin glargine in 2002 adults in a ratio (1:1:1:3) with T2D inadequately […]
The company recently published new results on its MOBILE study, which found that CGM use increased time in range for people with Type 2 diabetes. […]
Shots: The P-III SURPASS-3 MRI sub-study evaluates the effects of tirzepatide (5/10/15mg, qw) vs titrated insulin degludec on LFC, VAT and ASAT in 296 patients […]
The FDA has approved Bayer’s Kerendia to treat chronic kidney disease in patients with type 2 diabetes. The drug is the first in its class, […]
Date: July 12, 2021 Issue #: 1628 Summary: The injectable glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide, previously approved by the FDA as Ozempic to treat […]
Eli Lilly has scored five out of five with its phase 3 trials of type 2 diabetes candidate tirzepatide, setting up regulatory filings for a […]
Eli Lilly diabetes drug tirzepatide beat long-acting insulin in the last of a series of global studies designed to support regulatory submissions for the type […]
Shots: SURPASS-4 study involves assessing tirzepatide (5/10/15mg) vs insulin glargine in 2002 adults in a ratio (1:1:1:3) with T2D inadequately controlled with at least 1 […]
What You Should Know: – Virta Health, a San Francisco, CA-based company raises $133M led by , to scale its virtual metabolic clinic and approach […]
After announcing plans to go public, prescription digital therapeutics (DTx) firm Better Therapeutics has begun a “real world” study to test whether its BT-001 prescription […]
Digital health startup Better Therapeutics plans to go public through a SPAC merger that would value it at $187 million. The company is currently running […]
What You Should Know: – Blue Shield of California is enhancing its popular Wellvolution program by adding two new services that provide personalized care and […]
Shots: The companies expanded the collaboration to improve health for people with T2D. The agreement integrates the Dexcom G6 CGM system and Welldoc’s BlueStar digital […]
Shots: The US FDA has issued refusal to file a letter covering the label expansion application for semaglutide (2.0mg/qw) for T2D, which was submitted on […]
Shots: The P-III SURPASS-2 trial involves assessing Tirzepatide (5/10/15mg) vs Semaglutide (1mg) in 1,879 patients in a ratio (1:1:1:1) with T2D inadequately controlled with ≥1500 […]
Athar Siddiqui: Global Strategy Lead, Digital Connected Solutions – Ascensia Diabetes Care “Information technology and business are becoming inextricably interwoven. I don’t think anybody can […]
Shots: The P-lll SURPASS-3 study involves assessing Tirzepatide (5/10/15 mg) vs titrated insulin degludec in 1444 participants in a ratio (1:1:1:1) with T2D treated with […]
What You Should Know: – Verily’s Onduo, known for its tech-based solution for virtual diabetes management, is launching a new multi-condition platform that matches the right care to […]
What You Should Know: – DarioHealth, a Livongo competitor acquires musculoskeletal startup Upright for $31 million to expand their chronic condition management capabilities focused on […]
What You Should Know: – Teladoc Health and Dexcom announced an expanded partnership on a new offering measures the impact of continuous glucose monitoring and […]
Shots: The P-lll SURPASS-1 study involves assessing Tirzepatide as monothx. (5/10/15 mg) vs PBO in 478 patients in the ratio of (1:1:1:1) with T2D inadequately […]
What You Should Know: – Virta just closed a $65 Series D round, to scale its virtual clinic and approach to reversing chronic metabolic conditions […]
Shots: The P-III FIDELIO-DKD study in CKD and T2D enrolled over 13,000 patients with early kidney damage and more advanced stages of kidney disease. The […]
What You Should Know: – Omada’s diabetes prevention program will be available to Intermountain’s at-risk patient population as part of a limited engagement in 2020 […]
Bayer’s blockbuster ambitions for diabetic kidney disease (DKD) drug candidate finerenone look a lot firmer with the publication of data from the phase 3 FIDELIO-DKD […]
What You Should Know: – Today, Blue Cross and Blue Shield of North Carolina partners with Carrot Inc. and Virta Health to help address two […]
Date: October 19, 2020 Issue #: 1609 Summary: The FDA has approved two additional doses (3 mg and 4.5 mg) of the glucagon-like peptide-1 (GLP-1) […]
What You Should Know: – Virta is expanding its suite of treatment options to include prediabetes reversal, obesity reversal, and type 2 diabetes management. – […]
What You Should Know: – NIH awards funding for Rare and Atypical Diabetes Network, or RADIANT that will seek to discover the cause of several […]
Date: October 19, 2020 Issue #: 1609 Summary: The FDA has approved insulin lispro-aabc (Lyumjev – Lilly), a faster-acting formulation of insulin lispro (Humalog), for […]
What You Should Know: – DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center […]
– Lemonaid Health, a direct to consumer telehealth company raises $33M in Series B funding to expand the company’s medical team and number of services […]
Copyright © 2024 | WordPress Theme by MH Themes